FuregrelateAlternative Names: Furegrelic acid; U 63557A
Latest Information Update: 21 Mar 1997
At a glance
- Originator Pharmacia Corporation
- Class Antiplatelets; Benzofurans; Small molecules
- Mechanism of Action Thromboxane synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders; Thrombosis
Most Recent Events
- 21 Mar 1997 Discontinued-II for Thrombosis in USA (Unknown route)
- 21 Mar 1997 Discontinued-II for Arrhythmias in USA (Unknown route)
- 21 Mar 1997 Discontinued-II for Ischaemic heart disorders in USA (Unknown route)